Skip to main content
Premium Trial:

Request an Annual Quote

IBM, Cellomics Partner on HCS IT Infrastructure; Sell First System to EPOPlus

NEW YORK, Aug. 11 (GenomeWeb News) - IBM and Cellomics said yesterday that they have jointly developed a customized information technology solution for Cellomics' high-content screening platform.

 

The companies said that the first of these "turnkey" IT infrastructures has already been installed at EPOPlus, a biotech firm developing erythropoietin therapies.

 

The infrastructure, called the HCi Appliancel, includes Cellomics' High Content Informatics software with servers, storage and management software from IBM.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.